PNV (ASX) share price forecast & AI signal — Polynovo Limited
Week of 2026-10-30 · Health Care Equipment & Services
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in PNV
Polynovo Limited is a Health Care Equipment & Services stock listed on the ASX. For the week of 2026-10-30 the ACE machine-learning model rates it a SELL with high confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Polynovo Limited
Polynovo Ltd is a medical device company that designs, develops, and manufactures dermal regeneration solutions. Its products are used in the treatment of burns, surgical wounds, and other soft tissue defects.
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $0.89 |
| 2026-11-05 | $0.91 |
| 2026-11-04 | $0.88 |
| 2026-11-03 | $0.93 |
| 2026-11-02 | $0.91 |
| 2026-10-30 | $0.91 |
| 2026-10-29 | $0.88 |
PNV FAQ
Is Polynovo Limited (PNV) a buy or sell this week?
The ACE Stock Bots machine-learning model rates PNV a SELL for the week of 2026-10-30 with high confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for PNV?
Every week the model scores PNV across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Health Care Equipment & Services stocks on the ASX
This week's top ASX picks · All ASX stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.